TEICOPLANINA MYLAN 100mg powder for injection / infusion or oral solution medication leaflet

J01XA02 teicoplanin • Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials

Teicoplanin is a glycopeptide antibiotic used for the treatment of severe bacterial infections caused by Gram-positive bacteria, including skin, bone, and joint infections, as well as endocarditis. It works by inhibiting bacterial cell wall synthesis, thereby destroying the bacteria.

The medication is administered via intravenous or intramuscular injection, as directed by a doctor. The dosage and duration of treatment are adjusted based on the severity of the infection and the patient's response.

Patients should be monitored for potential side effects, such as injection site reactions, skin rashes, or changes in kidney function. It is important to inform the doctor of any unusual symptoms.

Common side effects include injection site reactions, skin rashes, and nausea. In rare cases, severe reactions such as kidney failure or serious allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about TEICOPLANINA MYLAN 100mg

Substance: teicoplanin

Date of last drug list: 01-04-2022

Commercial code: W68623003

Concentration: 100mg

Pharmaceutical form: powder for injection / infusion or oral solution

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MYLAN S.A.S. - FRANTA

Holder: MYLAN PHARMACEUTICALS LIMITED - IRLANDA

Number: 10990/2018/03

Shelf life: 2 years-sol. reconstituita/diluata-it is used immediately

Concentrations available for teicoplanin

100mg, 200mg, 400mg

Other substances similar to teicoplanin